New hand transplant protocol could reduce lifelong side effects

NCT ID NCT01459107

First seen May 15, 2026 · Last updated May 17, 2026 · Updated 1 time

Summary

This study aims to make hand transplantation safer and more effective for people who have lost a hand, forearm, or arm. The researchers are testing a new drug plan that combines immune cell depletion with donor bone marrow to lower the need for strong, lifelong anti-rejection drugs. Up to 30 adults with below-shoulder amputations will receive a hand transplant and be followed for 5 years to see if the graft survives and if the drug regimen can be reduced.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMPUTATION, TRAUMATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Johns Hopkins University School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.